* 1. In response to the FDA Extended-Release/Long-Acting Opioid Risk Evaluation and Mitigation Strategy (REMS), the Academy would like to know how often you prescribe extended-release or long-acting opioids
(i.e. oxycodone, methadone hydrochloride, morphine, oxymorphone)?

Information on this REMS can be found at http://www.er-la-opioidrems.com/IwgUI/rems/home.action.

T